Ra Medical Systems Reports First Quarter 2019 Financial Results

Go back to Ra Medical Systems Reports First Quarter 2019 Financial Results

Ra Medical Systems Inc. (RMED) PT Lowered to $10 at Cantor Fitzgerald

May 14, 2019 7:45 AM EDT

Cantor Fitzgerald analyst Craig Bijou lowered the price target on Ra Medical Systems Inc. (NYSE: RMED) to $10.00 (from $11.00) while maintaining a Overweight rating. The changes reflect Cantor Fitzgerald's slightly lower 2020 sales estimates and a contraction in comparable-company valuation multiples.

1Q revenue was... More

Ra Medical Systems (RMED) Misses Q1 EPS by 78c, Revenues Beat

May 13, 2019 4:14 PM EDT

Ra Medical Systems (NYSE: RMED) reported Q1 EPS of ($1.16), $0.78 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.23 million.

Im pleased to report that in the first quarter we completed the validation of our... More